The analysis revealed that 50% of healthy individuals showed no detectable IL-4 expression (mean: 1.4; median: 0), whereas IL-4 levels in PCa patients were approximately 30-fold higher (mean: 43; median: 42). Here, IL4 is linked to posterior cortical atrophy.